Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Daniel Virnich currently holds 2,360,224 shares of Oncology Institute, Inc. (TOI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Daniel Virnich has been a net seller of TOI stock. They have purchased $0 and sold $7.6K worth of shares.
Daniel Virnich's most recent insider trade was on Mar 27, 2026, when they sold 98,534 shares at $3.07 per share.
Daniel Virnich serves as Executive at Oncology Institute, Inc. (TOI). They have executed 18 insider transactions totaling $7.6K over their tenure at the company.
Daniel Virnich holds the position of Executive at Oncology Institute, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Daniel Virnich has shown a selling trading pattern, with $0 in total purchases and $7.6K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Daniel Virnich was on Mar 27, 2026, when they sold $302.5K worth of TOI shares. This transaction involved 98,534 shares at $3.07 per share.
Daniel Virnich currently owns 2,360,224 shares of Oncology Institute, Inc. (TOI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Daniel Virnich's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Daniel Virnich has 18 Form 4 filings on record as an insider at Oncology Institute, Inc..
Set alerts for Daniel Virnich and 40,000+ other insiders.